Simple test for cervical cancer
Source: Agencies |
January 16, 2010, Saturday
|
Print Edition
Print Edition
A SIMPLE "see and treat" approach using a test costing US$2 could prevent 100,000 cervical cancer deaths a year in women in poorer countries, British scientists said yesterday.
Cervical cancer is the leading cause of cancer death among women in developing nations where the main barriers to tackling the disease are poor health services and high costs of screening and vaccines.
But British researchers said visual inspection with acetic acid (VIA) -- which costs significantly less than US$9 human papillomavirus (HPV) or cervical cell lab tests -- could be the answer.
Around 300,000 women worldwide die from cervical cancer each year and up to 85 percent of those deaths occur in developing countries.
"VIA is an effective and affordable tool to screen women for pre-cancerous lesions of the cervix in under-resourced countries," said researcher David McGregor of University College London. "Coupled with simple treatment measures, VIA could potentially reduce these cancer deaths by a third, which means nearly 100,000 women saved each year."
VIA is a simple test where a very small dose of acetate acid solution is applied to the cervix to detect pre-cancerous lesions. A positive result can be treated immediately.
This is referred to as the "see and treat" approach and experts say it can work well in small clinics without advanced equipment and laboratories.
But unlike in developed nations, where cervical screening programs are well established and vaccination programs against HPV are growing, access to tests and vaccines in many countries in Africa, Asia and southern America is limited.
The study in the Obstetrician & Gynaecologist journal said research in rural and isolated communities had shown that VIA is accurate, acceptable to women, and cuts cancer death rates.
Cervical cancer is the leading cause of cancer death among women in developing nations where the main barriers to tackling the disease are poor health services and high costs of screening and vaccines.
But British researchers said visual inspection with acetic acid (VIA) -- which costs significantly less than US$9 human papillomavirus (HPV) or cervical cell lab tests -- could be the answer.
Around 300,000 women worldwide die from cervical cancer each year and up to 85 percent of those deaths occur in developing countries.
"VIA is an effective and affordable tool to screen women for pre-cancerous lesions of the cervix in under-resourced countries," said researcher David McGregor of University College London. "Coupled with simple treatment measures, VIA could potentially reduce these cancer deaths by a third, which means nearly 100,000 women saved each year."
VIA is a simple test where a very small dose of acetate acid solution is applied to the cervix to detect pre-cancerous lesions. A positive result can be treated immediately.
This is referred to as the "see and treat" approach and experts say it can work well in small clinics without advanced equipment and laboratories.
But unlike in developed nations, where cervical screening programs are well established and vaccination programs against HPV are growing, access to tests and vaccines in many countries in Africa, Asia and southern America is limited.
The study in the Obstetrician & Gynaecologist journal said research in rural and isolated communities had shown that VIA is accurate, acceptable to women, and cuts cancer death rates.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
